Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2V617F

被引：22
作者：
Hermouet, S. [1 ]
Dobo, I.
Lippert, E.
Boursier, M-C
Ergand, L.
Perrault-Hu, F.
Pineau, D.
机构：
[1] CHU Nantes, Hematol Lab, F-44035 Nantes 01, France
[2] CHU Angers, Hematol Lab, Angers, France
[3] Ctr Hosp Univ Bordeaux, Hematol Lab, Bordeaux, France
来源：
LEUKEMIA | 2007年 / 21卷 / 05期
关键词：
D O I：
10.1038/sj.leu.2404588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1128 / 1130
页数：3
相关论文
共 8 条
[1]   Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis [J].
Boissinot, Marjorie ;
Lippert, Eric ;
Girodon, Francois ;
Dobo, Irene ;
Fouassier, Marc ;
Masliah, Claude ;
Praloran, Vincent ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (09) :3223-3224
[2]   Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera [J].
Dobo, L ;
Donnard, M ;
Girodon, F ;
Mossuz, P ;
Boiret, N ;
Boukhari, R ;
Allègraud, A ;
Bascans, E ;
Campos, L ;
Pineau, D ;
Turlure, P ;
Praloran, V ;
Hermouet, S .
HEMATOLOGY JOURNAL, 2004, 5 (02) :161-167
[3]  
GIRODON F, IN PRESS HAEMATOLOGI
[4]   Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis [J].
James, C ;
Delhommeau, F ;
Marzac, C ;
Teyssandier, I ;
Le Couédic, JP ;
Giraudier, S ;
Roy, L ;
Saulnier, P ;
Lacroix, L ;
Maury, S ;
Tulliez, M ;
Vainchenker, W ;
Ugo, V ;
Casadevall, N .
LEUKEMIA, 2006, 20 (02) :350-353
[5]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[6]   Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders [J].
Kralovics, Robert ;
Teo, Soon-Siong ;
Li, Sai ;
Theocharides, Alexandre ;
Buser, Andreas S. ;
Tichelli, Andre ;
Skoda, Radek G. .
BLOOD, 2006, 108 (04) :1377-1380
[7]   The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera [J].
Lippert, Eric ;
Boissinot, Marjorie ;
Kralovics, Robert ;
Girodon, Francois ;
Dobo, Irene ;
Praloran, Vincent ;
Boiret-Dupre, Nathalie ;
Skoda, Radek C. ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (06) :1865-1867
[8]   Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders [J].
Passamonti, F ;
Rumi, E ;
Pietra, D ;
Della Porta, MG ;
Boveri, E ;
Pascutto, C ;
Vanelli, L ;
Arcaini, L ;
Burcheri, S ;
Malcovati, L ;
Lazzarino, M ;
Cazzola, M .
BLOOD, 2006, 107 (09) :3676-3682
1